The Royal Pharmaceutical Society of Great Britain has drawn up a list of 51 prescription drug products which it says could safely be switched to pharmacy status.
The list is based on the original recommendations accepted by the joint pharmacy profession/Department of Health working party, which published its report in March on ways in which the National Health Service community pharmaceutical services might be developed to increase their contribution to health care.
Discussing the report at a meeting organized by the Medicines Control Agency in London on the new POM-to-P switching (Marketletter October 26), Roger Odd, head of the practice division at the RPSGB, said the Society would be making further applications for products to be switched, following the success of its recommendation for switching of clotrimazole, miconazole, econazole and isoconazole for the treatment of vaginal thrush. However, another application by the Society, for triamcinolone dental paste, had been turned down.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze